FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912328038> ?p ?o ?g. }

• W2912328038 endingPage "316" @default.
• W2912328038 startingPage "316" @default.
• W2912328038 abstract "<h3>Importance</h3> Conversion to oral therapy for Enterobacteriaceae bacteremia has the potential to improve the quality of life of patients by improving mobility, eliminating catheter-associated discomfort, decreasing the risk for noninfectious and infectious catheter-associated adverse events, and decreasing health care costs. <h3>Objective</h3> To compare the association of 30-day mortality with early oral step-down therapy vs continued parenteral therapy for the treatment of Enterobacteriaceae bloodstream infections. <h3>Design, Setting, and Participants</h3> This retrospective multicenter cohort study included a 1:1 propensity score–matched cohort of 4967 unique patients hospitalized with monomicrobial Enterobacteriaceae bloodstream infection at 3 academic medical centers from January 1, 2008, through December 31, 2014. Eligibility criteria included appropriate source control measures, appropriate clinical response by day 5, active antibiotic therapy from day 1 until discontinuation of therapy, availability of an active oral antibiotic option, and ability to consume other oral medications or feeding. Statistical analysis was performed from March 2, 2018, to June 2, 2018. <h3>Exposures</h3> Oral step-down therapy within the first 5 days of treatment of Enterobacteriaceae bacteremia. <h3>Main Outcomes and Measures</h3> The main outcome was 30-day all-cause mortality. <h3>Results</h3> Of the 2161 eligible patients, 1185 (54.8%) were male and 1075 (49.7%) were white; the median (interquartile range [IQR]) age was 59 (48-68) years. One-to-one propensity-score matching yielded 1478 patients, with 739 in each study arm. Sources of bacteremia included urine (594 patients [40.2%]), gastrointestinal tract (297 [20.1%]), central line-associated (272 [18.4%]), pulmonary (58 [3.9%]), and skin and soft tissue (41 [2.8%]). There were 97 (13.1%) deaths in the oral step-down group and 99 (13.4%) in the intravenous (IV) group within 30 days (hazard ratio [HR], 1.03; 95% CI, 0.82-1.30). There were no differences in recurrence of bacteremia within 30 days between the groups (IV, 6 [0.8%]; oral, 4 [0.5%]; HR, 0.82 [0.33-2.01]). Patients transitioned to oral step-down therapy were discharged from the hospital an average of 2 days (IQR, 1-6) sooner than patients who continued to receive IV therapy (5 days [IQR, 3-8 days] vs 7 days [IQR, 4-14 days];<i>P</i> < .001). <h3>Conclusions and Relevance</h3> In this study, 30-day mortality was not different among hospitalized patients who received oral step-down vs continued parenteral therapy for the treatment of Enterobacteriaceae bloodstream infections. The findings suggest that transitioning to oral step-down therapy may be an effective treatment approach for patients with Enterobacteriaceae bacteremia who have received source control and demonstrated an appropriate clinical response. Early transition to oral step-down therapy may be associated with a decrease in the duration of hospital stay for patients with Enterobacteriaceae bloodstream infections." @default.
• W2912328038 created "2019-02-21" @default.
• W2912328038 creator A5013059068 @default.
• W2912328038 creator A5014755100 @default.
• W2912328038 creator A5017168855 @default.
• W2912328038 creator A5018437292 @default.
• W2912328038 creator A5021230105 @default.
• W2912328038 creator A5027736773 @default.
• W2912328038 creator A5030280540 @default.
• W2912328038 creator A5070260660 @default.
• W2912328038 creator A5073854380 @default.
• W2912328038 creator A5077194947 @default.
• W2912328038 creator A5090134158 @default.
• W2912328038 date "2019-03-01" @default.
• W2912328038 modified "2023-09-29" @default.
• W2912328038 title "Association of 30-Day Mortality With Oral Step-Down vs Continued Intravenous Therapy in Patients Hospitalized With Enterobacteriaceae Bacteremia" @default.
• W2912328038 cites W1561374298 @default.
• W2912328038 cites W1992175003 @default.
• W2912328038 cites W2012029168 @default.
• W2912328038 cites W2037554663 @default.
• W2912328038 cites W2064150502 @default.
• W2912328038 cites W2075310248 @default.
• W2912328038 cites W2093274439 @default.
• W2912328038 cites W2117129256 @default.
• W2912328038 cites W2139624885 @default.
• W2912328038 cites W2159689977 @default.
• W2912328038 cites W2166356134 @default.
• W2912328038 cites W2344123002 @default.
• W2912328038 cites W2508190125 @default.
• W2912328038 cites W2747159366 @default.
• W2912328038 cites W2753529248 @default.
• W2912328038 cites W2780846751 @default.
• W2912328038 cites W2788258230 @default.
• W2912328038 cites W2788691011 @default.
• W2912328038 cites W2789393455 @default.
• W2912328038 cites W4238233986 @default.
• W2912328038 cites W4238983047 @default.
• W2912328038 cites W4253438888 @default.
• W2912328038 doi "https://doi.org/10.1001/jamainternmed.2018.6226" @default.
• W2912328038 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6439703" @default.
• W2912328038 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30667477" @default.
• W2912328038 hasPublicationYear "2019" @default.
• W2912328038 type Work @default.
• W2912328038 sameAs 2912328038 @default.
• W2912328038 citedByCount "81" @default.
• W2912328038 countsByYear W29123280382019 @default.
• W2912328038 countsByYear W29123280382020 @default.
• W2912328038 countsByYear W29123280382021 @default.
• W2912328038 countsByYear W29123280382022 @default.
• W2912328038 countsByYear W29123280382023 @default.
• W2912328038 crossrefType "journal-article" @default.
• W2912328038 hasAuthorship W2912328038A5013059068 @default.
• W2912328038 hasAuthorship W2912328038A5014755100 @default.
• W2912328038 hasAuthorship W2912328038A5017168855 @default.
• W2912328038 hasAuthorship W2912328038A5018437292 @default.
• W2912328038 hasAuthorship W2912328038A5021230105 @default.
• W2912328038 hasAuthorship W2912328038A5027736773 @default.
• W2912328038 hasAuthorship W2912328038A5030280540 @default.
• W2912328038 hasAuthorship W2912328038A5070260660 @default.
• W2912328038 hasAuthorship W2912328038A5073854380 @default.
• W2912328038 hasAuthorship W2912328038A5077194947 @default.
• W2912328038 hasAuthorship W2912328038A5090134158 @default.
• W2912328038 hasBestOaLocation W29123280381 @default.
• W2912328038 hasConcept C119060515 @default.
• W2912328038 hasConcept C126322002 @default.
• W2912328038 hasConcept C141071460 @default.
• W2912328038 hasConcept C167135981 @default.
• W2912328038 hasConcept C177713679 @default.
• W2912328038 hasConcept C17923572 @default.
• W2912328038 hasConcept C195910791 @default.
• W2912328038 hasConcept C201903717 @default.
• W2912328038 hasConcept C2778715236 @default.
• W2912328038 hasConcept C2779443120 @default.
• W2912328038 hasConcept C501593827 @default.
• W2912328038 hasConcept C71924100 @default.
• W2912328038 hasConcept C72563966 @default.
• W2912328038 hasConcept C78722104 @default.
• W2912328038 hasConcept C86803240 @default.
• W2912328038 hasConcept C89423630 @default.
• W2912328038 hasConceptScore W2912328038C119060515 @default.
• W2912328038 hasConceptScore W2912328038C126322002 @default.
• W2912328038 hasConceptScore W2912328038C141071460 @default.
• W2912328038 hasConceptScore W2912328038C167135981 @default.
• W2912328038 hasConceptScore W2912328038C177713679 @default.
• W2912328038 hasConceptScore W2912328038C17923572 @default.
• W2912328038 hasConceptScore W2912328038C195910791 @default.
• W2912328038 hasConceptScore W2912328038C201903717 @default.
• W2912328038 hasConceptScore W2912328038C2778715236 @default.
• W2912328038 hasConceptScore W2912328038C2779443120 @default.
• W2912328038 hasConceptScore W2912328038C501593827 @default.
• W2912328038 hasConceptScore W2912328038C71924100 @default.
• W2912328038 hasConceptScore W2912328038C72563966 @default.
• W2912328038 hasConceptScore W2912328038C78722104 @default.
• W2912328038 hasConceptScore W2912328038C86803240 @default.
• W2912328038 hasConceptScore W2912328038C89423630 @default.
• W2912328038 hasIssue "3" @default.
• W2912328038 hasLocation W29123280381 @default.
• W2912328038 hasLocation W29123280382 @default.

• next